Business Description
Longboard Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US54300N1037
Description
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 77.25 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -43.2 | |||||
| 3-Year EPS without NRI Growth Rate | -41.1 | |||||
| 3-Year FCF Growth Rate | -122.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.8 | |||||
| 9-Day RSI | 81.58 | |||||
| 14-Day RSI | 79.7 | |||||
| 6-1 Month Momentum % | 199.65 | |||||
| 12-1 Month Momentum % | 1166.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.97 | |||||
| Quick Ratio | 15.97 | |||||
| Cash Ratio | 15.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.2 | |||||
| Shareholder Yield % | -13.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -39.09 | |||||
| ROA % | -36.45 | |||||
| ROIC % | -1587.63 | |||||
| ROC (Joel Greenblatt) % | -3484.62 | |||||
| ROCE % | -44.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.51 | |||||
| Price-to-Tangible-Book | 8.51 | |||||
| EV-to-EBIT | -23.52 | |||||
| EV-to-EBITDA | -23.53 | |||||
| EV-to-Forward-EBITDA | -16.03 | |||||
| EV-to-FCF | -31.2 | |||||
| Price-to-Net-Current-Asset-Value | 8.63 | |||||
| Price-to-Net-Cash | 8.78 | |||||
| Earnings Yield (Greenblatt) % | -4.25 | |||||
| FCF Yield % | -2.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LBPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Longboard Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.23 | ||
| Beta | 1.41 | ||
| Volatility % | 254.71 | ||
| 14-Day RSI | 79.7 | ||
| 14-Day ATR ($) | 0.243391 | ||
| 20-Day SMA ($) | 59.911 | ||
| 12-1 Month Momentum % | 1166.53 | ||
| 52-Week Range ($) | 4.71 - 60.03 | ||
| Shares Outstanding (Mil) | 39.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Longboard Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Longboard Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Longboard Pharmaceuticals Inc Frequently Asked Questions
What is Longboard Pharmaceuticals Inc(LBPH)'s stock price today?
The current price of LBPH is $59.98. The 52 week high of LBPH is $60.03 and 52 week low is $4.71.
When is next earnings date of Longboard Pharmaceuticals Inc(LBPH)?
The next earnings date of Longboard Pharmaceuticals Inc(LBPH) is 2025-03-12 Est..
Does Longboard Pharmaceuticals Inc(LBPH) pay dividends? If so, how much?
Longboard Pharmaceuticals Inc(LBPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers